NEUARTIGE VERBINDUNGEN

Patent europeic · EP2922549 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2922549
Numer da la dumonda
EP13857477
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-11-2013
Publitgà
30-09-2015
Concedì
21-06-2017
Stritgà
30-11-2019
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/519 (2006.01)
C07D 487/04 (2006.01)
Prioritad
US 201261728390 P 20.11.2012
US 201361774087 P 07.03.2013
Dumonda PCT
PCT/US2013/070472 18.11.2013
Publicaziun PCT
WO2014/081645 30.05.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-06-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 17.06.2020

  2. 10-08-2017

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 10.08.2017

  3. 21-06-2017

    Concedì

    Published in Swissreg on 21.06.2017

Partidas

Possessur

GlaxoSmithKline LLC

Corporation Service Company 251 Little Falls Drive, Wilmington, Delaware 19808, US

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

COE, Diane Mary

Stevenage Hertfordshire SG1 2NY, GB

SMITH, Stephen Allan

Stevenage Hertfordshire SG1 2NY, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.